Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Medicinal Chemistry

• Publication date

  2011-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/092986711795933687PMID 21568899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p62/Sequestosome-1 Associates with and Sustains the Expression of Retroviral Restriction Factor TRIM5α

  2010cited by this paper
• TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys

  2010cited by this paper
• Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus.

  2010cited by this paper
• Inhibitory effect of human TRIM5alpha on HIV-1 production.

  2010cited by this paper
• Identifying and characterizing recently transmitted viruses

  2010cited by this paper
• Human cellular restriction factors that target HIV-1 replication

  2009cited by this paper
• TRIM5alpha.

  2009cited by this paper
• Human TRIM Gene Expression in Response to Interferons

  2009cited by this paper
• Identification of Postentry Restrictions to Mason-Pfizer Monkey Virus Infection in New World Monkey Cells

  2008cited by this paper
• Biochemical Characterization of a Recombinant TRIM5α Protein That Restricts Human Immunodeficiency Virus Type 1 Replication

  2008cited by this paper
• Human Immunodeficiency Virus Type 1 Restriction by Human–Rhesus Chimeric Tripartite Motif 5α (TRIM 5α) in CD34+ Cell-Derived Macrophages In Vitro and in T Cells In Vivo in Severe Combined Immunodeficient (SCID-hu) Mice Transplanted with Human Fetal Tissue

  2008cited by this paper
• Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities

  2008cited by this paper
• Proteasomal Degradation of TRIM5α during Retrovirus Restriction

  2008cited by this paper
• TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis

  2008cited by this paper
• The TRIM5α B-Box 2 Domain Promotes Cooperative Binding to the Retroviral Capsid by Mediating Higher-Order Self-Association

  2008cited by this paper
• Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.

  2008cited by this paper
• Restriction of Foamy Viruses by Primate Trim5α

  2008cited by this paper
• TRIM5alpha-independent anti-human immunodeficiency virus type 1 activity mediated by cyclophilin A in Old World monkey cells.

  2008cited by this paper
• Host factors involved in resistance to retroviral infection

  2008cited by this paper
• A brief history of TRIM5alpha.

  2007cited by this paper
• The control of viral infection by tripartite motif proteins and cyclophilin A

  2007cited by this paper
• Modulation of Retroviral Restriction and Proteasome Inhibitor-Resistant Turnover by Changes in the TRIM5α B-Box 2 Domain

  2007cited by this paper
• Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

  2006cited by this paper
• Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding.

  2006cited by this paper
• Cyclophilin A interacts with diverse lentiviral capsids

  2006cited by this paper
• Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5α Antiviral Activity

  2006cited by this paper
• Cyclophilin A: an auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1.

  2006cited by this paper
• Structural and functional insights into the B30.2/SPRY domain

  2006cited by this paper
• Removal of Arginine 332 Allows Human TRIM5α To Bind Human Immunodeficiency Virus Capsids and To Restrict Infection

  2006cited by this paper
• Implications for viral capsid assembly from crystal structures of HIV-1 Gag(1-278) and CA(N)(133-278).

  2006cited by this paper
• Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.

  2006cited by this paper
• Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection

  2006cited by this paper
• How TRIM5alpha defends against retroviral invasions.

  2006cited by this paper
• Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins

  2006cited by this paper
• All Three Variable Regions of the TRIM5α B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction

  2006cited by this paper
• The Contribution of RING and B-box 2 Domains to Retroviral Restriction Mediated by Monkey TRIM5α*

  2005cited by this paper
• Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 Infection

  2005cited by this paper
• Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5α Alleles

  2005cited by this paper
• Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells

  2005cited by this paper
• Species-Specific Variation in the B30.2(SPRY) Domain of TRIM5α Determines the Potency of Human Immunodeficiency Virus Restriction

  2005cited by this paper
• TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages.

  2005cited by this paper
• Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.

  2005cited by this paper
• TRIM5α selectively binds a restriction-sensitive retroviral capsid

  2005cited by this paper
• TRIM5alpha association with cytoplasmic bodies is not required for antiretroviral activity.

  2005cited by this paper
• Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.

  2005cited by this paper
• Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity

  2005cited by this paper
• A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons.

  2005cited by this paper
• TRIM family proteins: retroviral restriction and antiviral defence

  2005cited by this paper
• Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs.

  2004cited by this paper
• Species-Specific Tropism Determinants in the Human Immunodeficiency Virus Type 1 Capsid

  2004cited by this paper
• Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity

  2004cited by this paper
• The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

  2004cited by this paper
• Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

  2004cited by this paper
• Intrinsic immunity: a front-line defense against viral attack

  2004cited by this paper
• Binding and Susceptibility to Postentry Restriction Factors in Monkey Cells Are Specified by Distinct Regions of the Human Immunodeficiency Virus Type 1 Capsid

  2004cited by this paper
• Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.

  2004cited by this paper
• Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells

  2003cited by this paper
• Hassles with Taking Out the Garbage: Aggravating Aggresomes

  2002cited by this paper
• Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A

  2002cited by this paper
• The tripartite motif family identifies cell compartments

  2001cited by this paper
• Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle

  1997cited by this paper
• Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses

  1996cited by this paper
• Functional association of cyclophilin A with HIV-1 virions

  1994cited by this paper
• Specific incorporation of cyclophilin A into HIV-1 virions

  1994cited by this paper
• Cytoplasmic activation of GAF, an IFN‐gamma‐regulated DNA‐binding factor.

  1991cited by this paper

• Complete Genome and Molecular Characterization of a New Cyprinid Herpesvirus 2 (CyHV-2) SH-01 Strain Isolated from Cultured Crucian Carp

  2022cites this paper
• Impact of cellular restriction gene (TRIM5α, BST‐2) polymorphisms on the acquisition of HIV‐1 and disease progression

  2018cites this paper
• Retroviral restriction: nature's own solution

  2016cites this paper
• Anti-HIV Factors: Targeting Each Step of HIV's Replication Cycle.

  2016cites this paper
• Potent restriction of HIV-1 and SIVmac239 Replication by African Green Monkey TRIM5α

  2015cites this paper
• Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

  2015cites this paper
• Animal Models Used in HIV Gene Therapy

  2014cites this paper
• Anti-HIV-1 activity of Trim 37.

  2014cites this paper
• Gene Therapy for HIV

  2014cites this paper
• Non-Simian Foamy Viruses: Molecular Virology, Tropism and Prevalence and Zoonotic/Interspecies Transmission

  2013cites this paper